InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Poly(I:C) LMW | Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... | 2021 | Cancer Immunol Immunother | Hänel G. et al. | DOI: 10.1007/s00262-021-03109-w |
| Normocin® - Antimicrobial Reagent | CAF promotes chemoresistance through NRP2 in gastric cancer. | 2021 | Gastric Cancer | Yang Y. et al. | DOI: 10.1007/s10120-021-01270-w |
| Pam3CSK4 | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Poly(I:C) HMW | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| R848 (Resiquimod) | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Luc™: Luciferase Detection Reagent | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Zeocin® | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Blasticidin | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| THP1-Dual™ Cells | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Blue™ | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| HEK-Blue™ Null1 Cells | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| LyoVec™ | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| HEK-Blue™ Null1-k Cells | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| HEK-Blue™ Detection | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| Human TLR8 Reporter HEK293 Cells (NF-κB) | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| ODN 1668 - TLR9 ligand | Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agoni... | 2021 | J Immunother Cancer | Alvarez M. et al. | DOI: 10.1136/jitc-2021-002953 |
| DMXAA | Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agoni... | 2021 | J Immunother Cancer | Alvarez M. et al. | DOI: 10.1136/jitc-2021-002953 |
| ODN 1585 - TLR9 ligand | Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agoni... | 2021 | J Immunother Cancer | Alvarez M. et al. | DOI: 10.1136/jitc-2021-002953 |
| ODN 2395 - TLR9 ligand | Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agoni... | 2021 | J Immunother Cancer | Alvarez M. et al. | DOI: 10.1136/jitc-2021-002953 |